Cellular Therapy
Cellular therapy leverages living cells—hematopoietic, mesenchymal, and engineered immune cells (e.g., CAR/TCR constructs and iPSC-derived products)—to repair tissue, modulate inflammation, combat infection, and promote regeneration after polytrauma. Military applications require scalable manufacturing, cold‑chain resilient logistics, rapid potency assays, and safety controls for austere and prolonged‑field‑care settings.
Technical Challenges
Scalable GMP manufacturing and reproducible potency across batches
Cold chain, cryopreservation and supply logistics for far‑forward deployment
Immune compatibility, risk of GVHD, cytokine release and long‑term safety
Integration of cell therapy with polytrauma care, infection and hemorrhage management
Standardized clinical endpoints and regulatory pathways for trauma‑focused indications
Emerging Opportunities
Point‑of‑care or bedside cell processing and closed‑system bioreactors
Off‑the‑shelf, low‑immunogenic allogeneic products with proven durability
Ambient‑stable formulations or lightweight cryo‑solutions for prolonged field care
Rapid, predictive potency and biomarker assays linked to clinical outcomes
Consensus military‑relevant trial endpoints and translational pipelines
Current and Emerging Technologies in Cellular Therapy
Mesenchymal stromal cell (MSC) therapies
Allogeneic and autologous MSCs for immunomodulation, wound healing, and mitigation of inflammation after blast or hemorrhagic injury; focus on standardized potency assays and scalable expansion.
Engineered immune cells (CAR, TCR and macrophage therapies)
Targeted cellular immunotherapies are being adapted for antimicrobial resistance, persistent infection and biofilm disruption as well as tumor and dysregulated immune responses following trauma.
iPSC and progenitor cell‑derived allogeneic products
Induced pluripotent stem cell platforms enable scalable, off‑the‑shelf tissues and cell lines for musculoskeletal repair, nerve regeneration, and organ support with gene editing for reduced immunogenicity.
Point‑of‑care manufacturing and closed‑system bioreactors
Portable, closed‑system devices for rapid cell isolation, expansion and formulation at or near the point of injury to support prolonged field care and reduce reliance on long logistics chains.
Cryopreservation, lyophilization and ambient stabilization
Innovations in cold‑chain reduction, dry‑storage and reconstitution methods to enable deployment of cell therapies in austere and maritime environments with limited refrigeration.
Analytics: single‑cell, potency and rapid biomarker assays
Single‑cell profiling, functional potency assays and rapid diagnostics that correlate product attributes to clinical outcomes and shorten regulatory qualification timelines.
Importance to Military Medicine
Improve survival and functional recovery after polytrauma
Cellular approaches can accelerate tissue repair, reduce fibrosis and restore function after blast, burn and complex orthopedic injuries that are common in combat.
Enable prolonged and distributed care
Portable or shelf‑stable cell therapies support prolonged field care when evacuation is delayed, reducing complications from infection and chronic wound progression.
Address infection and antibiotic resistance
Immune cell and engineered cell platforms offer novel strategies against AMR pathogens and biofilms where conventional antibiotics fail, protecting force readiness.
Enhance readiness and rapid return to duty
Timely regeneration and reduced morbidity shorten recovery timelines, preserve unit capability, and minimize long‑term disability in deployed personnel.
Alignment with the MTEC Mission
Accelerates translation of cell therapies into operational use by connecting researchers, clinicians, and DoD stakeholders.
Prioritizes solutions for austere and prolonged‑field care consistent with MTEC’s focus on military‑relevant medical technologies.
Supports dual‑use outcomes—accelerating civilian benefit from trauma, reconstructive and infectious‑disease applications.
Leverages MTEC’s consortium model to integrate GMP manufacturing, regulatory expertise, and clinical trial networks for rapid field adoption.
Dual-Use (Military + Civilian) Applications
Trauma and reconstructive care: accelerate bone, nerve and soft tissue repair for combat casualties and civilian trauma patients.
Infectious disease: engineered immune cells and cell‑based antimicrobial strategies to counter AMR and biofilms.
Chronic wound and orthopedics: cell matrices and grafts to restore function and reduce long‑term disability in austere settings.
Disaster and remote medicine: deployable cell therapies for mass‑casualty events and humanitarian missions with dual civilian benefit.
Explore MTEC Members with Cellular Therapy Capabilities
MTEC members bring cross‑cutting strengths: GMP manufacturing partners, translational research teams, DoD clinical sites, and regulatory expertise to accelerate military‑relevant cell therapies from concept to clinic.
Explore member profiles to identify collaborators with point‑of‑care device experience, cryostorage solutions, clinical trial networks, and dual‑use commercialization pathways.
110 Members with Cellular Therapy capabilities.
The University of Texas System is a leading public university system in the United States, dedicated to improving lives through education, health care, and research. With over 256,000 students enrolled across 14 institutions, the UT System is committed to providing affordable access to higher education and producing a skilled workforce to drive Texas's economy.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization dedicated to advancing the bioeconomy of the United States. Its mission encompasses enhancing manufacturing, healthcare, and education and workforce development, aiming to create a scalable and effective manufacturing ecosystem for engineered cells, tissues, and organs.
Georgia Southern University is a vibrant institution with over 26,100 students across three campuses in Statesboro, Savannah, and Hinesville. The university offers 132 degree programs at the associate, bachelor’s, master’s, and doctorate levels, emphasizing student success, community impact, and research excellence. With a commitment to inclusivity and engagement, Georgia Southern fosters a supportive environment for diverse learners, including military-affiliated and adult students. The university is dedicated to transforming lives through education and community engagement, aligning its programs with regional needs. Additionally, Georgia Southern provides accelerated pathways for students to fast-track their master's degrees, enhancing educational opportunities. The university also emphasizes career readiness and public impact research, preparing students for successful careers and contributing to community development.
FiteBac Technology/FiteBac Pharma's K21 uniquely targets the underlying disease state, given that most diseases involve microbial-associated inflammation and mitochondrial dysfunction. FiteBac Technology innovations stem from the work of numerous international academic research scientists. FiteBac Pharma K21 is the blockbuster antimicrobial small molecule designed to modulate biological, immunological, and metabolic systems for treating a wide range of infectious and inflammatory diseases. This patented drug substance has demonstrated the ability to safely eliminate bacterial, fungal, and viral infections, enhance innate immunity, induce mitophagy while improving mitochondrial and cellular metabolism, accelerate wound healing, and even promote the development of zebrafish and chickens, leading to increased adult mass. Rigorous research from Dr. Bhupesh Prusty's laboratory and Dr Christopher Rongo's laboratory is focused on various aspects of mitochondrial remodeling and reprograming, as well as mitochondrial-to-nuclear signaling with K21.
Humanetics Corporation is a clinical-stage pharmaceutical company based in Minneapolis, Minnesota, focused on developing and commercializing products to enhance human health and wellbeing. Founded in 1988, the company specializes in radiation modulators, adjunctive oncology therapies, and pulmonary protective therapies, particularly for COVID-19. Humanetics is known for its lead drug candidate, BIO 300, which is being developed as a radioprotectant for military and civilian use, as well as a treatment to improve outcomes in cancer patients receiving radiotherapy. The company is actively engaged in research programs for non-small cell lung cancer, prostate cancer, and head and neck cancers.
The University of Texas at San Antonio (UTSA) is dedicated to the advancement of knowledge through research, teaching, and community engagement. As a premier public research university, UTSA embraces multicultural traditions and serves as a catalyst for socioeconomic development, providing access to educational excellence and preparing citizen leaders for the global environment.
Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.
The Institute for Integrative & Innovative Research (I³R) at the University of Arkansas is dedicated to pioneering solutions to wicked problems and societal challenges through convergence research. With a mission to advance research excellence and stimulate economic development, I³R focuses on deploying innovations at scale through collaboration across various sectors, including academia, industry, and government.
UTMB is dedicated to supporting research, education, and scholarly endeavors, with a focus on creating the future of healthcare through innovative research and community engagement.
Revolution Biomanufacturing Inc. (RBIx) is expanding beyond traditional CDMO Process/Analytical Development and Manufacturing services to pioneer distributed molecular manufacturing. A new class of digital biomanufacturing that enables the autonomous design, manufacture, quality verification, and deployment of Nucleic Acid therapeutics and molecular diagnostics at the point of need. By integrating AI-driven sequence optimization, enzymatic nucleic acid synthesis, Nanoparticle design and manufacturing (LNP & EV), closed-loop quality control, and field-deployable manufacturing platforms, RBIx is creating adaptive biological infrastructure capable of responding to emerging diseases, national security threats, and personalized medicine with unprecedented speed and flexibility.
The University of Chicago is a prestigious urban research university committed to rigorous inquiry and intellectual freedom. Founded in 1890, it has produced numerous Nobel laureates and is known for its transformative education and groundbreaking research across various fields. The university fosters an inclusive and diverse learning environment, encouraging participation from all community members.
Boston University is a major research institution committed to leading breakthroughs across various disciplines. The Office of Research supports and advances research excellence, fostering collaboration among researchers, industry partners, and government leaders to address significant societal challenges.
Cooper University Health Care is a regional academic health system recognized for comprehensive clinical services, advanced multidisciplinary care, specialized surgery, and robust research in South Jersey. It provides integrated healthcare across general and specialty domains, including cancer, neurosciences, cardiology, trauma, genetics, addiction medicine, and complex surgical procedures, supported by leading technologies and a network of modern facilities.
Baylor University is a preeminent Christian research university committed to addressing the world's most meaningful challenges through top-tier research and scholarship. Recognized as an R1 research institution, Baylor focuses on infusing its distinct Christian mission into its research initiatives, fostering a commitment to excellence and innovation.
This organization specializes in integrated, science-based treatment and diagnostics for Alzheimer’s, dementia, and cognitive decline. Utilizing a precision medicine approach, the center combines advanced AI analysis, biomarker-driven planning, and multimodal therapies including brain imaging, neurocognitive testing, and over 50 clinical and supportive treatment modalities. The care model addresses both the root causes and neuropsychiatric aspects of cognitive impairment, delivered by a multidisciplinary team with expertise in functional, regenerative, and collaborative behavioral medicine.
Stream Biomedical is a clinical-stage biotechnology company developing first-in-class biologic therapies to restore neurological function by activating the brain’s natural repair mechanisms. Founded in 2016, the company is advancing a protein therapeutic focusing on treating brain injuries and neurodegenerative diseases—including stroke, traumatic brain injury, and Alzheimer’s disease—by supporting neurovascular repair and modulating inflammation. Stream Biomedical’s approach is underpinned by rigorous preclinical and translational research, with the goal of changing outcomes for patients affected by severe neurological conditions.
NIRSense
Rugged Physiological Monitoring for the Modern Warfighter: NIRSense
Under MTEC-21-10-NavyMultiTopic, NIRSense is advancing its tactical jet physiological monitoring technology for broader Navy applications. The project focuses on ruggedized, wireless physiological sensors that can provide reliable, real-time insight into warfighter health and performance in demanding operational environments.
Safi Biotherapeutics
Next-Generation Manufactured Red Blood Cells for Extended Battlefield Blood Supply: Safi Biotherapeutics
Safi Biotherapeutics is developing manufactured red blood cells (mRBCs) with extended shelf life to improve battlefield transfusion readiness and emergency trauma care.
Non-Invasive Glymphatic (GF) Monitoring and Recovery Optimization for Warfighter Cognitive Readiness
Applied Cognition is developing non-invasive glymphatic monitoring and recovery technologies to enhance warfighter cognitive readiness, resilience, and sleep recovery.
Moberg Analytics
Moberg Analytics – Advanced Brain Monitoring & Critical Care Informatic
Moberg’s platform unifies brain monitoring data for faster, precise treatment of severe brain injuries in military and civilian care.